Diabetes, Vol 43, Issue 1 161-165, Copyright © 1994 by American Diabetes Association

ARTICLES

GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes

E Bjork, LA Velloso, O Kampe and FA Karlsson
Department of Internal Medicine, University Hospital, Uppsala, Sweden.

Glutamic acid decarboxylase (GAD) is a major islet cell autoantigen in insulin-dependent diabetes mellitus (IDDM), and autoantibodies are found in high frequencies in patients with recent-onset IDDM, stiff-man syndrome (SMS), and autoimmune polyendocrine syndrome type I (APS I). Antigens in autoimmune disorders are often enzymes, and autoantibody binding frequently inhibit their activity. In this study, we examined the reactivity of anti-GAD-containing sera from 7 patients with IDDM, 4 patients with SMS, and 5 patients with APS I. All sera immunoprecipitated GAD from [35S]methionine-labeled rat islet lysates and the sera from patients with SMS and APS I, but none of the IDDM patients' sera, identified the GAD protein in Western blots. Two of four SMS patients' sera and 5 of 5 APS I patients' sera, in contrast to 0 of 7 IDDM patients' sera, inhibited the enzymatic activity of GAD. When the various sera were tested with the GAD65 and GAD67 isoforms, produced separately by transient expression in COS cells, the enzymatic activity of GAD65 was inhibited by sera from patients with SMS and APS I, whereas no effect on the GAD67 activity was observed. Taken together, the results demonstrate that the GAD autoantibodies in these three disorders display marked differences in epitope recognition and indicate that, during the development of the diseases, the autoantigen is being presented to the immune system through separate pathogenetic mechanisms.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. S. Hampe, R. Nalini, M. R. Maldonado, T. R. Hall, G. Garza, D. Iyer, and A. Balasubramanyam Association of Amino-Terminal-Specific Antiglutamate Decarboxylase (GAD65) Autoantibodies with {beta}-Cell Functional Reserve and a Milder Clinical Phenotype in Patients with GAD65 Antibodies and Ketosis-Prone Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 462 - 467. [Abstract] [Full Text] [PDF]

				A. S. B. Wolff, M. M. Erichsen, A. Meager, N. F. Magitta, A. G. Myhre, J. Bollerslev, K. J. Fougner, K. Lima, P. M. Knappskog, and E. S. Husebye Autoimmune Polyendocrine Syndrome Type 1 in Norway: Phenotypic Variation, Autoantibodies, and Novel Mutations in the Autoimmune Regulator Gene J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 595 - 603. [Abstract] [Full Text] [PDF]

				M. S Ronkainen, T. Harkonen, J. Perheentupa, and M. Knip Characterization of the humoral immune response to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and/or type 1 diabetes Eur. J. Endocrinol., December 1, 2005; 153(6): 901 - 906. [Abstract] [Full Text] [PDF]

				R. Raju, J. Foote, J. P. Banga, T. R. Hall, C. J. Padoa, M. C. Dalakas, E. Ortqvist, and C. S. Hampe Analysis of GAD65 Autoantibodies in Stiff-Person Syndrome Patients J. Immunol., December 1, 2005; 175(11): 7755 - 7762. [Abstract] [Full Text] [PDF]

				C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark Autoantibodies in Diabetes Diabetes, December 1, 2005; 54(suppl_2): S52 - S61. [Abstract] [Full Text] [PDF]

				F. Skoldberg, F. Rorsman, J. Perheentupa, M. Landin-Olsson, E. S. Husebye, J. Gustafsson, and O. Kampe Analysis of Antibody Reactivity against Cysteine Sulfinic Acid Decarboxylase, A Pyridoxal Phosphate-Dependent Enzyme, in Endocrine Autoimmune Disease J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1636 - 1640. [Abstract] [Full Text] [PDF]

				C. J. Padoa, J. P. Banga, A.-M. Madec, M. Ziegler, M. Schlosser, E. Ortqvist, I. Kockum, J. Palmer, O. Rolandsson, K. A. Binder, et al. Recombinant Fabs of Human Monoclonal Antibodies Specific to the Middle Epitope of GAD65 Inhibit Type 1 Diabetes-Specific GAD65Abs Diabetes, November 1, 2003; 52(11): 2689 - 2695. [Abstract] [Full Text] [PDF]

				T. Kobayashi, S. Tanaka, M. Okubo, K. Nakanishi, T. Murase, and A. Lernmark Unique Epitopes of Glutamic Acid Decarboxylase Autoantibodies in Slowly Progressive Type 1 Diabetes J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4768 - 4775. [Abstract] [Full Text] [PDF]

				F. Skoldberg, G. M. Portela-Gomes, L. Grimelius, G. Nilsson, J. Perheentupa, C. Betterle, E. S. Husebye, J. Gustafsson, A. Ronnblom, F. Rorsman, et al. Histidine Decarboxylase, a Pyridoxal Phosphate-Dependent Enzyme, Is an Autoantigen of Gastric Enterochromaffin-Like Cells J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1445 - 1452. [Abstract] [Full Text] [PDF]

				C. S. Hampe, L. P. Hammerle, L. Bekris, E. Örtqvist, I. Kockum, O. Rolandsson, M. Landin-Olsson, C. Törn, B. Persson, and A. Lernmark Recognition of Glutamic Acid Decarboxylase (GAD) by Autoantibodies from Different GAD Antibody-Positive Phenotypes J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4671 - 4679. [Abstract] [Full Text]

				A. Falorni, G. Gambelunghe, F. Forini, G. Kassi, A. Cosentino, P. Candeloro, G. B. Bolli, P. Brunetti, and F. Calcinaro Autoantibody Recognition of COOH-Terminal Epitopes of GAD65 Marks the Risk for Insulin Requirement in Adult-Onset Diabetes Mellitus J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 309 - 316. [Abstract] [Full Text]

				A. Söderbergh, F. Rorsman, M. Halonen, O. Ekwall, P. Björses, O. Kämpe, and E. S. Husebye Autoantibodies against Aromatic L-Amino Acid Decarboxylase Identifies a Subgroup of Patients with Addison's Disease J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 460 - 463. [Abstract] [Full Text]

				C. Betterle, N. A. Greggio, and M. Volpato Autoimmune Polyglandular Syndrome Type 1 J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1049 - 1055. [Full Text]

				J. L. Black, E. M. Barth, D. E. Williams, and J. A. Tinsley Stiff-Man Syndrome: Results of Interviews and Psychologic Testing Psychosomatics, February 1, 1998; 39(1): 38 - 44. [Abstract] [Full Text]

				J. Tremble, N. G. Morgenthaler, A. Vlug, A. C. Powers, M. R. Christie, W. A. Scherbaum, and J. P. Banga Human B Cells Secreting Immunoglobulin G to Glutamic Acid Decarboxylase-65 from a Nondiabetic Patient with Multiple Autoantibodies and Graves' Disease: A Comparison with Those Present in Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2664 - 2670. [Abstract] [Full Text] [PDF]

				E. S. Husebye, G. Gebre-Medhin, T. Tuomi, J. Perheentupa, M. Landin-Olsson, J. Gustafsson, F. Rorsman, and O. Kampe Autoantibodies against Aromatic L-Amino Acid Decarboxylase in Autoimmune Polyendocrine Syndrome Type I J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 147 - 150. [Abstract] [Full Text] [PDF]